Market Overview
The Cardiovascular Devices market is predicted to develop at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2034, when it is projected to reach USD 112.95 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 64.88 Billion in 2024.
SOURCE: We Market Research
Medical
instruments called cardiovascular devices are used to identify, track, and
treat disorders of the heart and blood vessels. Important instances include
heart valve replacement or repair, stents to maintain arterial patency,
pacemakers to control cardiac rhythms, and catheters for therapeutic or
diagnostic purposes such as angioplasty. Additional devices include heart pumps
like LVADs to help the heart pump blood, implanted cardioverter defibrillators
(ICDs) to correct severe arrhythmias, cardiac monitors to continuously observe
heart activity, and electrocardiogram (ECG) equipment to record heart activity.
The quality of life and overall health of patients are greatly improved by
these devices in the management and treatment of cardiovascular illnesses.
The ageing
population, the increasing incidence of cardiovascular illnesses, and technical
developments in medical devices are the main drivers of the cardiovascular
devices industry. The market is expected to rise as a result of enhanced
healthcare infrastructure, regular screening for cardiac problems, increased
awareness of the ailment, and encouraging government initiatives. The need for
these devices is further fueled by changes in lifestyle that result in
increased incidences of obesity, diabetes, and hypertension. Furthermore,
growing healthcare spending encourages market expansion. Together, these
elements promote the development and uptake of cardiovascular devices,
enhancing patient outcomes and propelling worldwide market expansion.
Market Scope
Report Attributes |
Description |
Market Size in 2024 |
USD 64.88 Billion |
Market Forecast in 2034 |
USD 112.95 Billion |
CAGR % 2024-2034 |
5.7% |
Base Year |
2023 |
Historic Data |
2016-2022 |
Forecast Period |
2024-2034 |
Report USP Â |
Production, Consumption, company share, company
heatmap, company production capacity, growth factors and more |
Segments Covered |
By Device Type, By Application, By End-User and By Region |
Regional Scope |
North America, Europe, APAC, South America and
Middle East and Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic
Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia;
Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa;
Nigeria |
Â
Cardiovascular Devices Industry: Dynamics & Restrains
We Market
Research: Cardiovascular Devices
Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Cardiovascular Devices Segmentation
Market- By Device Type Analysis
By Device Type, the Cardiovascular Devices Market is Categories into Diagnostic and Monitoring Devices, Therapeutic and Surgical Devices. The Therapeutic and Surgical Devices segment accounts for the largest share of around 61% in 2024.
The drivers for therapeutic and surgical devices
in the global cardiovascular devices market include increasing prevalence of
cardiovascular diseases, advancements in technology, rising geriatric
population, improved healthcare infrastructure, and growing demand for
minimally invasive procedures.
The
following segments are part of an in-depth analysis of the global Cardiovascular
Devices market:
Market Segments |
 |
By   Application |
·       Â
Coronary Artery Disease (CAD) ·       Â
Cardiac Arrhythmia ·       Â
Heart Failure |
By  End-User |
·       Â
Hospitals ·       Â
Specialty Clinics |
Â
Cardiovascular Devices Industry: Regional Analysis
North America Market Forecast
North America dominate the Cardiovascular Devices Market with the highest revenue generating market with share of more than 47%. North America leads the Cardiovascular Devices market, driven by advanced healthcare infrastructure supporting extensive device usage, strong market presence of leading manufacturers, and substantial healthcare expenditure enabling adoption of advanced technologies. Challenges include high costs of devices and healthcare services.
Europe Market Statistics
Europe's Cardiovascular
Devices market is second largest market. Europe has a significant share in the Cardiovascular
Devices market due to increasing incidence of cardiovascular diseases due to
aging population and lifestyle changes, well-established healthcare systems
supporting device adoption, and favorable reimbursement policies encouraging
market growth. Challenges include stringent regulatory frameworks and economic
variations impacting healthcare investments.
Asia Pacific Market Forecasts
Asia Pacific is
expected to be the fastest-growing regional segment of the Cardiovascular
Devices market during the forecast period. In the Asia Pacific region, rapid
urbanization and lifestyle changes leading to increased cardiovascular disease
prevalence, improving healthcare infrastructure expanding access to devices,
rising disposable incomes supporting healthcare spending, and growing awareness
of heart health. Challenges include disparities in healthcare access between
urban and rural areas.
Key Market Players
The Cardiovascular
Devices Market is dominated by a few large companies, such as
·       Â
Boston Scientific Corporation
·       Â
Terumo Cardiovascular Systems
Corporation
·       Â
B. Braun Melsungen AG
·       Â
LivaNova PLC
·       Â
Siemens Healthcare GmbH
·       Â
Medtronic
·       Â
Abbott
·       Â
Edwards Lifesciences
Corporation
·       Â
Johnson & Johnson Services,
Inc.
·        GENERAL ELECTRIC COMPANY
·         Other
1.    Â
Global
Cardiovascular Devices Market Introduction and Market Overview
1.1.   Objectives of the Study
1.2.   Global Cardiovascular Devices
Market Scope and Market Estimation
1.2.1. Global Cardiovascular Devices Overall
Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)
1.2.2. Global Cardiovascular Devices
Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3.   Market Segmentation
1.3.1. Device Type of Global Cardiovascular
Devices Market
1.3.2. Application of Global Cardiovascular
Devices Market
1.3.3. End-User of Global Cardiovascular
Devices Market
1.3.4. Region of Global Cardiovascular
Devices Market
2.    Â
Executive Summary
2.1.   Market Dynamics
2.1.1. Drivers
2.1.2. Limitations
2.1.3. Opportunities
2.1.4. Impact Analysis of Drivers and
Restraints
2.2.   Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.3.   Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.4.   Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitutes
2.4.4. Threat of New Entrants
2.4.5. Competitive Rivalry
2.5.     Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.    Â
Global Cardiovascular Devices
Market Estimates & Historical Trend
Analysis (2019 - 2023)
4.    Â
Global Cardiovascular Devices
Market Estimates & Forecast Trend
Analysis, By Device Type
4.1.   Global Cardiovascular Devices
Market Revenue (US$ Mn) Estimates and Forecasts, By Device Type , 2019 to 2034
4.1.1. Diagnostic and Monitoring
Devices
4.1.2. Therapeutic and Surgical Devices
5.    Â
Global Cardiovascular Devices
Market Estimates & Forecast Trend
Analysis, by Application
5.1.   Global Cardiovascular Devices
Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034
5.1.1. Coronary Artery Disease (CAD)
5.1.2. Cardiac Arrhythmia
5.1.3. Heart Failure
6.    Â
Global Cardiovascular Devices
Market Estimates & Forecast Trend
Analysis, by End-User
6.1.   Global Cardiovascular Devices
Market Revenue (US$ Mn) Estimates and Forecasts, by End-User,
2019 to 2034
6.1.1. Hospitals
6.1.2. Specialty Clinics
7.    Â
Global Cardiovascular Devices
Market Estimates & Forecast Trend
Analysis, by Region
7.1.   Global Cardiovascular Devices
Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Middle East & Africa
7.1.5. South America
8.    Â
North
America Cardiovascular Devices Market: Estimates & Forecast Trend Analysis
8.1.  Â
North
America Cardiovascular Devices Market Assessments & Key Findings
8.1.1. North America Cardiovascular
Devices Market Introduction
8.1.2. North America Cardiovascular
Devices Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
8.1.2.1.  By Device Type
8.1.2.2.  By Application
8.1.2.3.  By End-User
8.1.2.4.  By Country
8.1.2.4.1.    The U.S.
8.1.2.4.2.    Canada
8.1.2.4.3.    Mexico
9.    Â
Europe
Cardiovascular Devices Market: Estimates & Forecast Trend Analysis
9.1.   Europe Cardiovascular Devices
Market Assessments & Key Findings
9.1.1. Europe Cardiovascular Devices
Market Introduction
9.1.2. Europe Cardiovascular Devices
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
9.1.2.1.  By Device Type
9.1.2.2.  By Application
9.1.2.3.  By End-User
9.1.2.4.      Â
By
Country
9.1.2.4.1.    Germany
9.1.2.4.2.    U.K.
9.1.2.4.3.    France
9.1.2.4.4.    Italy
9.1.2.4.5.    Spain
9.1.2.4.6.    Russia
9.1.2.4.7.    Rest of Europe
10. Asia Pacific Cardiovascular
Devices Market: Estimates &
Forecast Trend Analysis
10.1. Asia Pacific Market Assessments
& Key Findings
10.1.1.  Asia Pacific Cardiovascular
Devices Market Introduction
10.1.2.  Asia Pacific Cardiovascular
Devices Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
10.1.2.1.   By Device Type
10.1.2.2.   By Application
10.1.2.3.   By End-User
10.1.2.4.   By Country
10.1.2.4.1. China
10.1.2.4.2. Japan
10.1.2.4.3. India
10.1.2.4.4. Australia
10.1.2.4.5. South Korea
10.1.2.4.6. ASEAN
10.1.2.4.7. Rest of Asia Pacific
11. Middle East & Africa Cardiovascular
Devices Market: Estimates &
Forecast Trend Analysis
11.1. Middle East & Africa Market
Assessments & Key Findings
11.1.1.  Middle
East & Africa Cardiovascular
Devices Market Introduction
11.1.2.  Middle
East & Africa Cardiovascular
Devices Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
11.1.2.1.   By Device Type
11.1.2.2.   By Application
11.1.2.3.   By End-User
11.1.2.4.   By Country
11.1.2.4.1. U.A.E.
11.1.2.4.2. Saudi Arabia
11.1.2.4.3. Egypt
11.1.2.4.4. South Africa
11.1.2.4.5. Rest of Middle East & Africa
12. South America
Cardiovascular Devices Market:
Estimates & Forecast Trend Analysis
12.1. South America Market Assessments
& Key Findings
12.1.1.  South America Cardiovascular
Devices Market Introduction
12.1.2.  South America Cardiovascular
Devices Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
12.1.2.1.   By Device Type
12.1.2.2.   By Application
12.1.2.3.   By End-User
12.1.2.4.   By Country
12.1.2.4.1. Brazil
12.1.2.4.2. Argentina
12.1.2.4.3. Colombia
12.1.2.4.4. Rest of South America
13. Competition Landscape
13.1. Global Cardiovascular Devices
Market Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
13.2. Global Cardiovascular Devices
Market Competition White Space Analysis, By End-user
13.3. Global Cardiovascular Devices
Market Competition Heat Map Analysis, By End-user
13.4. Global Cardiovascular Devices
Market Concentration & Company Market Shares (%) Analysis, 2022
14. Company Profiles
14.1.                   Â
Boston Scientific Corporation
14.1.1.  Company Overview & Key Stats
14.1.2.  Financial Performance & KPIs
14.1.3.  Product Portfolio
14.1.4.  Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned belowÂ
14.2.     Terumo
Cardiovascular Systems Corporation
14.3.     B. Braun
Melsungen AG
14.4.     LivaNova PLC
14.5.     Siemens
Healthcare GmbH
14.6.     Medtronic
14.7.     Abbott
14.8.     Edwards
Lifesciences Corporation
14.9.     Johnson &
Johnson Services, Inc.
14.10. GENERAL
ELECTRIC COMPANY
14.11. Other
15. Research
Methodology
15.1. External Transportations /
Databases
15.2. Internal Proprietary Database
15.3. Primary Research
15.4. Secondary Research
15.5. Assumptions
15.6. Limitations
15.7. Report FAQs
16. Research Findings & Conclusion
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Cardiovascular Devices Market was valued at USD 64.88 Billion in 2024.
Cardiovascular Devices Market size will increase at approximate CAGR of 5.7% during the forecasted period.
Major companies operating within the Cardiovascular Devices Market Are Boston Scientific Corporation,Terumo Cardiovascular Systems Corporation , B. Braun, Melsungen AG , LivaNova PLC , Siemens Healthcare GmbH , Medtronic , Abbott , Edwards Lifesciences Corporation , Johnson & Johnson Services, Inc., GENERAL ELECTRIC COMPANY and Other.
North America dominates the market with an active share of 47%.
Only Three Thousand Four Hundred Ninety Nine US dollar
Only Four Thousand Four Hundred Ninety Nine US dollar
Only Five Thousand Four Hundred Ninety Nine US dollar